Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPAAC: Levocetirizine for Asthma Prevention
NCT00152464Phase 3Completed
- Sponsor
- UCB
- Start
- Mar 2002
- Primary completion
- Mar 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Levocetirizine with Placebo (2 arms). Primary endpoint: Time to Onset of Asthma During the Treatment Period at 18 months. Started Mar 2002; status: completed.
02
Drugs
levocetirizine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00152464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152464.